Dude, i think we both know that you are out over your skis on this.
The work of clinical trials continues.
The work of agency public communications, processing of regulations, and the conduct of government meetings does not, for the moment. Maybe you're right - it may be a long, or too long, 'moment' - even for these limited things, and the ability to communicate the actual research in public fora, for example, could become adversely affected. Or, to take another example, the ability to issue public health related information. But new administrations issue hard agency pauses like the ones described, though this one is to be sure probably harder than some have been. Sometimes - probably not at nih - that's because outgoing administrations go out of their way to put stuff in the pipeline to gum up the plumbing.
But as far as "reading beyond the headline," well, it was your headline, and frankly, it was a good one because it got me to take a peek a the thread. But when I did, there wasn't anything in your post to read. So I did look at various external stories, and saw nothing about the suspension of NIH research. Still happy to be enlightened. BTW, I do know at least a little about how academic and clinical research, including at NIH, works, both professionally and by virtue of my SIL having been a pretty senior researcher there.